CRYOPORT, INC. Amortization of Intangible Assets
CRYOPORT, INC. (CYRX) reported Amortization of Intangible Assets of $3.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- CRYOPORT, INC. amortization of intangible assets for the quarter ending 2026-06-30 was $3.40M, a 9.68% increase year-over-year.
- CRYOPORT, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $3.10M, a 0.00% change year-over-year.
- CRYOPORT, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $3.20M, a 3.23% increase year-over-year.
- CRYOPORT, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $3.20M, a 3.23% increase year-over-year.
- CRYOPORT, INC. amortization of intangible assets for fiscal 2025 was $12.70M, a 1.60% increase from fiscal 2024.
- CRYOPORT, INC. amortization of intangible assets for fiscal 2024 was $12.50M, a 2.46% increase from fiscal 2023.
- CRYOPORT, INC. amortization of intangible assets for fiscal 2023 was $12.20M, a 19.21% decline from fiscal 2022.
- CRYOPORT, INC. amortization of intangible assets for fiscal 2022 was $15.10M, a 4.86% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.40M 10-Q · filed 2026-08-06 | $6.50M 10-Q · filed 2026-08-06 | $9.70M derived: sum of 3 quarters · filed 2026-08-06 | $12.90M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $3.10M 10-Q · filed 2026-05-05 | $6.30M derived: sum of 2 quarters · filed 2026-05-05 | $9.50M derived: sum of 3 quarters · filed 2026-05-05 | $12.60M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $6.40M derived: sum of 2 quarters · filed 2026-03-05 | $9.50M derived: sum of 3 quarters · filed 2026-08-06 | $12.70M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $3.20M 10-Q · filed 2025-11-06 | $6.30M derived: sum of 2 quarters · filed 2026-08-06 | $9.50M 10-Q · filed 2025-11-06 | $12.50M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $3.10M 10-Q · filed 2026-08-06 | $6.30M 10-Q · filed 2026-08-06 | $9.30M derived: sum of 3 quarters · filed 2026-08-06 | $12.40M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $3.10M 10-Q · filed 2026-05-05 | $6.20M derived: sum of 2 quarters · filed 2026-05-05 | $9.30M derived: sum of 3 quarters · filed 2026-05-05 | $12.40M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $6.20M derived: sum of 2 quarters · filed 2026-03-05 | $9.30M derived: sum of 3 quarters · filed 2026-03-05 | $12.50M 10-K · filed 2026-03-05 | $17.00M 10-K · filed 2025-03-07 | |||
| 2024-09-30 | $3.10M 10-Q · filed 2025-11-06 | $4.30M 10-Q · filed 2024-11-07 | $6.20M derived: sum of 2 quarters · filed 2025-11-06 | $9.40M 10-Q · filed 2025-11-06 | $13.00M 10-Q · filed 2024-11-07 | $9.80M derived: sum of 4 quarters · filed 2026-03-05 | ||
| 2024-06-30 | $3.10M 10-Q · filed 2025-08-12 | $4.30M 10-Q · filed 2024-08-08 | $6.30M 10-Q · filed 2025-08-12 | $8.70M 10-Q · filed 2024-08-08 | $6.70M derived: sum of 3 quarters · filed 2026-03-05 | $10.70M derived: sum of 4 quarters · filed 2026-03-05 | ||
| 2024-03-31 | $3.10M 10-Q · filed 2025-05-08 | $4.40M 10-Q · filed 2024-05-08 | $3.60M derived: sum of 2 quarters · filed 2026-03-05 | $7.60M derived: sum of 3 quarters · filed 2026-03-05 | $11.50M derived: sum of 4 quarters · filed 2026-03-05 | |||
| 2023-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $4.50M derived: sum of 2 quarters · filed 2026-03-05 | $8.40M derived: sum of 3 quarters · filed 2026-03-05 | $12.20M 10-K · filed 2026-03-05 | $16.30M 10-K · filed 2024-03-13 | |||
| 2023-09-30 | $4.00M 10-Q · filed 2024-11-07 | $7.90M derived: sum of 2 quarters · filed 2024-11-07 | $11.70M 10-Q · filed 2024-11-07 | $15.60M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-06-30 | $3.90M 10-Q · filed 2024-08-08 | $7.70M 10-Q · filed 2024-08-08 | $11.60M derived: sum of 3 quarters · filed 2025-03-07 | $15.00M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-03-31 | $3.80M 10-Q · filed 2024-05-08 | $7.70M derived: sum of 2 quarters · filed 2025-03-07 | $11.10M derived: sum of 3 quarters · filed 2025-03-07 | $14.80M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2022-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $7.30M derived: sum of 2 quarters · filed 2025-03-07 | $11.00M derived: sum of 3 quarters · filed 2025-03-07 | $15.10M 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | $3.40M 10-Q · filed 2023-11-09 | $7.10M derived: sum of 2 quarters · filed 2023-11-09 | $11.20M 10-Q · filed 2023-11-09 | $14.50M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-06-30 | $3.70M 10-Q · filed 2023-08-09 | $7.50M 10-Q · filed 2023-08-09 | $11.10M derived: sum of 3 quarters · filed 2024-03-13 | $14.80M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-03-31 | $3.80M 10-Q · filed 2022-05-05 | $7.40M derived: sum of 2 quarters · filed 2024-03-13 | $11.10M derived: sum of 3 quarters · filed 2024-03-13 | $14.70M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2021-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $7.30M derived: sum of 2 quarters · filed 2024-03-13 | $10.90M derived: sum of 3 quarters · filed 2024-03-13 | $14.40M 10-K · filed 2024-03-13 | ||||
| 2021-09-30 | $3.70M 10-Q · filed 2022-11-04 | $7.30M derived: sum of 2 quarters · filed 2022-11-04 | $10.80M 10-Q · filed 2022-11-04 | $17.10M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $3.60M 10-Q · filed 2022-08-04 | $7.10M 10-Q · filed 2022-08-04 | $13.40M derived: sum of 3 quarters · filed 2023-02-28 | $13.50M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $3.60M 10-Q · filed 2022-05-05 | $9.80M derived: sum of 2 quarters · filed 2023-02-28 | $9.90M derived: sum of 3 quarters · filed 2023-02-28 | $10.00M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $6.30M derived: sum of 2 quarters · filed 2023-02-28 | $6.40M derived: sum of 3 quarters · filed 2023-02-28 | $6.60M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $100.00K 10-Q · filed 2021-11-04 | $134.25K 10-Q · filed 2020-11-06 | $200.00K derived: sum of 2 quarters · filed 2021-11-04 | $400.00K 10-Q · filed 2021-11-04 | $402.80K 10-Q · filed 2020-11-06 | $455.30K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | $100.00K 10-Q · filed 2021-08-06 | $134.25K 10-Q · filed 2020-08-10 | $300.00K 10-Q · filed 2021-08-06 | $268.50K 10-Q · filed 2020-08-10 | $355.30K derived: sum of 3 quarters · filed 2022-02-28 | $489.60K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | $134.30K 10-Q · filed 2020-05-08 | $255.30K derived: sum of 2 quarters · filed 2022-02-28 | $389.60K derived: sum of 3 quarters · filed 2022-02-28 | $434.40K derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $255.30K derived: sum of 2 quarters · filed 2022-02-28 | $300.10K derived: sum of 3 quarters · filed 2022-02-28 | $300.00K 10-K · filed 2022-02-28 | $313.30K 10-K · filed 2020-03-10 | |||
| 2019-09-30 | $134.30K 10-Q · filed 2020-11-06 | $179.10K derived: sum of 2 quarters · filed 2020-11-06 | $179.00K 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | $44.80K 10-Q · filed 2020-08-10 | $44.80K 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-08 | |||||||
| 2018-12-31 | $0.00 10-K · filed 2020-03-10 | |||||||
| 2017-12-31 | $0.00 10-K · filed 2019-03-13 | |||||||
| 2016-12-31 | $8.60K 10-K · filed 2018-03-08 | |||||||
| 2016-03-31 | $30.10K 10-KT · filed 2017-03-13 | |||||||
| 2015-03-31 | $43.20K 10-K · filed 2016-06-28 | |||||||
| 2014-03-31 | $9.03K derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-19 | $36.75K derived: sum of 2 quarters · filed 2015-05-19 | $64.48K derived: sum of 3 quarters · filed 2015-05-19 | $92.20K 10-K · filed 2015-05-19 | ||||
| 2013-12-31 | $27.72K 10-Q · filed 2014-02-13 | $55.45K derived: sum of 2 quarters · filed 2014-02-13 | $83.17K 10-Q · filed 2014-02-13 | $110.94K derived: sum of 4 quarters · filed 2014-06-25 | ||||
| 2013-09-30 | $27.72K 10-Q · filed 2013-11-18 | $55.45K 10-Q · filed 2013-11-18 | $83.21K derived: sum of 3 quarters · filed 2014-06-25 | $110.36K derived: sum of 4 quarters · filed 2014-06-25 | ||||
| 2013-06-30 | $27.72K 10-Q · filed 2013-08-14 | $55.49K derived: sum of 2 quarters · filed 2014-06-25 | $82.64K derived: sum of 3 quarters · filed 2014-06-25 | $111.83K derived: sum of 4 quarters · filed 2014-06-25 | ||||
| 2013-03-31 | $27.77K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-25 | $54.91K derived: sum of 2 quarters · filed 2014-06-25 | $84.11K derived: sum of 3 quarters · filed 2014-06-25 | $112.30K 10-K · filed 2014-06-25 | $112.26K 10-K · filed 2013-06-25 | |||
| 2012-12-31 | $27.15K 10-Q · filed 2014-02-13 | $56.34K derived: sum of 2 quarters · filed 2014-02-13 | $84.53K 10-Q · filed 2014-02-13 | $111.98K derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-09-30 | $29.20K 10-Q · filed 2013-11-18 | $57.38K 10-Q · filed 2013-11-18 | $84.83K derived: sum of 3 quarters · filed 2013-11-18 | $110.95K derived: sum of 4 quarters · filed 2013-11-18 | ||||
| 2012-06-30 | $28.19K 10-Q · filed 2013-08-14 | $55.63K derived: sum of 2 quarters · filed 2013-08-14 | $81.75K derived: sum of 3 quarters · filed 2013-08-14 | $105.66K derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | $27.44K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | $53.56K derived: sum of 2 quarters · filed 2013-06-25 | $77.47K derived: sum of 3 quarters · filed 2013-06-25 | $101.19K 10-K · filed 2013-06-25 | ||||
| 2011-12-31 | $26.12K 10-Q · filed 2013-02-14 | $50.03K derived: sum of 2 quarters · filed 2013-02-14 | $73.75K 10-Q · filed 2013-02-14 | |||||
| 2011-09-30 | $23.91K 10-Q · filed 2012-11-09 | $47.63K 10-Q · filed 2012-11-09 | ||||||
| 2011-06-30 | $23.72K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |